The antibiotic used to treat trachoma, “the world’s leading preventable cause of blindness,” may also protect children living in Ethiopia from death from of other diseases, according to a recent study, the Associated Press reports.
Kenya on Thursday launched a national malaria campaign to encourage Kenyans to sleep under insecticide-treated nets (ITNs) every night to prevent infection, the Daily Nation reports.
GlaxoSmithKline Begins Testing H1N1 Vaccine; Opinion Piece Addresses U.S. Role In Helping Developing Countries Procure Vaccine
“GlaxoSmithKline has started testing its pandemic H1N1 swine flu vaccine in humans, and expects to start giving the results to government agencies next month, the drug maker said on Friday,” Reuters reports.
A PLoS Neglected Tropical Diseases study found how a new drug developed by scientists in China effectively kills roundworms â€“ “a parasite that lurks in the intestines and which affects nearly two billion people in tropical countries,” Reuters reports.
New research has found that drug-resistant strains of tuberculosis are just as likely to be transmitted between people as drug-sensitive TB, which could make drug-resistant forms of the disease “highly prevalent in the next few decades,” the Australian Associated Press/Sydney Morning Herald reports (Rose, 8/11).
Former President Bill Clinton on Thursday announced deals with drugmakers Matrix Laboratories and Pfizer to lower the cost of medications to treat patients with drug-resistant forms of HIV/AIDS in the developing world, Reuters reports.
In October, Ghana’s Ministry of Health plans to begin a national program to eliminate malaria with the goal of being the first country in Africa to eradicate the disease, George Sipa-Adjah Yankey, the minister of health, said recently at the 74th Annual Conference of the Pharmaceutical Society of Ghana in Accra, Ghana, GNA/Homepage Ghana reports.
Artemisinin, the “basis of the most effective” malaria treatment recommended by the WHO, took nearly twice as long to clear malaria parasites in patients in western Cambodia than it did in patients in northwestern Thailand, according to a New England Journal of Medicine study, which shows the “drugs are losing their power against the disease in Cambodia,” Bloomberg reports.
PBS’ Online NewsHour examines how “poor-quality and counterfeit malaria drugs” in Cambodia is contributing to a “growing resistance to treatment for the disease near the Thai-Cambodian border.”
The Drugs Controller General of India (DCGI) asked state drug licensing authorities to avoid authorizing new licenses for single drug formulations of artemisinin and withdraw existing licences for these types of drugs by the end of this month, livemint.com reports.